JENIFER SLEIGHT: Open Payments
NPI 1144632761 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,916 in 69 payments from 17 companies in 2025. Trend: 2023 $1,337 · 2024 $1,005 · 2025 $1,916
Food & beverage: $1,916
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $351 |
| ABBVIE INC. | 8 | $260 |
| Lilly USA, LLC | 2 | $239 |
| AstraZeneca Pharmaceuticals LP | 4 | $205 |
| Novo Nordisk Inc | 11 | $166 |
| Otsuka America Pharmaceutical, Inc. | 13 | $161 |
| Axsome Therapeutics, Inc. | 5 | $147 |
| LEO Pharma Inc. | 1 | $107 |
| Sumitomo Pharma America, Inc. | 1 | $104 |
| Lundbeck LLC | 2 | $36 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, ZEPBOUND, AIRSUPRA, ANZUPGO, GEMTESA.
Industry payments across MI — which companies pay providers there.
